Europe • Euronext Oslo • OSL:CONTX • SE0014731154
The current stock price of CONTX.OL is 3.7 NOK. In the past month the price decreased by -4.57%. In the past year, price decreased by -29.06%.
ChartMill assigns a technical rating of 1 / 10 to CONTX.OL. When comparing the yearly performance of all stocks, CONTX.OL is a bad performer in the overall market: 86.86% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL. While CONTX.OL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months CONTX.OL reported a non-GAAP Earnings per Share(EPS) of 0.05. The EPS decreased by -83.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.17% | ||
| ROA | 3.07% | ||
| ROE | 3.95% | ||
| Debt/Equity | 0.07 |
7 analysts have analysed CONTX.OL and the average price target is 4.08 NOK. This implies a price increase of 10.27% is expected in the next year compared to the current price of 3.7.
For the next year, analysts expect an EPS growth of -103.45% and a revenue growth -17.19% for CONTX.OL
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EQS | EQUASENS | 13.08 | 603.766M | ||
| GPI | GPI SPA | 17.51 | 511.129M | ||
| ALCGM | CEGEDIM SA | 7.97 | 187.53M | ||
| ALMDT | MEDIAN TECHNOLOGIES | N/A | 165.791M | ||
| AGFB | AGFA-GEVAERT NV | 9.51 | 75.242M | ||
| AJ91 | DOCCHECK AG | N/A | 64.896M | ||
| M3V | MEVIS MEDICAL SOLUTIONS AG | N/A | 44.408M | ||
| ALINS | INTRASENSE SAS | N/A | 13.18M | ||
| MLLAB | MEDIA LAB SPA | N/A |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
CONTEXTVISION AB
Hollandargatan 13, 2 tr
Stockholm STOCKHOLM SE
Employees: 42
Phone: 4687503550
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
The current stock price of CONTX.OL is 3.7 NOK. The price decreased by -1.6% in the last trading session.
CONTEXTVISION AB (CONTX.OL) has a dividend yield of 4.18%. The yearly dividend amount is currently 0.
CONTX.OL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CONTX.OL.
CONTEXTVISION AB (CONTX.OL) has a market capitalization of 286.27M NOK. This makes CONTX.OL a Micro Cap stock.